Dose Ranging Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism
NCT00004699
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
8
Enrollment
OTHER
Sponsor class
Conditions
Hyperinsulinism
Interventions
DRUG:
insulin-like growth factor I
Sponsor
Children's Hospital of Philadelphia